OAPC Dopamine Agonists in Type 2 Diabetes

This Oxford American Pocket Cards source of information is developed by MedHand Mobile Libraries. Improve your performance with relevant, valid material which is accessed quickly and with minimal effort in the palm of your hand. Diabetes is the most prevalent metabolic disorder in the world. With many types of therapies available, including the mainstay insulin, the disease is manageable in most people. However, current anti-diabetes medications act primarily on peripheral end organs to regulate glucose and insulin levels. Dopamine agonist therapy, which targets the neuroendocrine patterns associated with insulin resistance, is a novel approach for diabetes treatment.Part of the Oxford American Pocket Cards series, this portable, ultra-concise and up-to-date brochure provides key clinical insight as well as dosing and administration guidelines for newly FDA-approved dopamine agonist therapy for Type 2 diabetes.Author: Vivian Fonseca ________________________________________ MedHand Mobile Libraries offers a SUBSCRIPTION FREE application without edition upgrade. MedHand is the exclusive partner of Oxford University Press, publishing the latest editions of their Medical Handbooks in digital format.MedHand offers user-friendly, quick and intuitive applications for medical books on iPhone, iPad and iPod Touch, supporting you with mobile knowledge at the point of care. Offering the most trusted and well recognized medical guidelines provided by excellent publishers. MedHand delivers what you need, trusted knowledge at the point of care!
Price USD 4.99
License Purchase
File Size 1.74 MB
Version 2.1.1
Operating System iOS
System Requirements Compatible with iPhone, iPod Touch, and iPad. Requires iOS 3.1 or later. iTunes account required